RT @RuthClifford5: Unmet needs in the modern treatment of CLL. Nice 👌🏻 @anthonymatomd @tobyeyre82
Unmet needs in the modern treatment of CLL. Nice 👌🏻 @anthonymatomd @tobyeyre82
RT @anthonymatomd: Our editorial published in @CCR_AACR today highlighting the biggest unmet needs in #CLL. 1. Management of BTKi / Ven e…
RT @DrRaulCordoba: #Hematology Recognizing Unmet Need in the Era of #TargetedTherapy for #CLL/SLL: “What's Past Is Prologue” (Shakespeare)…
#Hematology Recognizing Unmet Need in the Era of #TargetedTherapy for #CLL/SLL: “What's Past Is Prologue” (Shakespeare) | Clinical Cancer Research #lymsm #leusm CC @anthonymatomd https://t.co/kPANfgL2Si
RT @anthonymatomd: Our editorial published in @CCR_AACR today highlighting the biggest unmet needs in #CLL. 1. Management of BTKi / Ven e…
.@anthonymatomd - a Renaissance man quoting Shakespeare
New article: Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past is Prologue" (Shakespeare) https://t.co/MDYf1j1ecI #CLL #leusm #hematology
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past is Prologue" (Shakespeare) https://t.co/DmEv6Cpm9Q # CLL
RT @MCThompsonMD: Recommended reading that highlights the continued unmet needs for patients with CLL in 2021. Stay tuned for data to be pr…
RT @MCThompsonMD: Recommended reading that highlights the continued unmet needs for patients with CLL in 2021. Stay tuned for data to be pr…
Recommended reading that highlights the continued unmet needs for patients with CLL in 2021. Stay tuned for data to be presented at #ASH21 abstract 2628 that further highlights that existing standard therapies have poor outcomes in CLL patients after expos